Emory University in Atlanta, Georgia, is actively recruiting for the Cohort 0 control groupin the CYStem clinical trial.
While the control group will not receive a transplant, participation is important to the success of this clinical trial. By providing a baseline for comparison, Cohort 0 will help researchers understand the true effects of stem cell therapy and advance treatments for those affected by cystinosis.
Key Details:
- Cohort 0 Study Site: Emory University, Atlanta, GA
- Principal Investigator: Dr. Larry Greenbaum
- Age Range: 2 to 6 years old
- Time Commitment: 5 in-person visits over 2 years
- Costs: All travel and participation expenses are covered by the study
More information is available through the official study listing at ClinicalTrials.gov or call the Emory study site at 404-712-6374.
Meet the Investigator in Person
Dr. Larry Greenbaum, Principal Investigator for the Emory site, will be available to answer questions and share more about the study at the CRN Family Conference this July. Be sure to visit his booth for a chance to engage directly. Registration and details are posted here.